These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 1982701)
21. Use of angiotensin converting enzyme inhibitors. Chatterjee K Heart Dis Stroke; 1992; 1(3):128-33. PubMed ID: 1344097 [No Abstract] [Full Text] [Related]
22. What to treat? The structural basis for renal and vascular complications and hypertension, and the role of angiotensin converting enzyme inhibition. Symposium, 26th meeting of the European Association for the Study of Diabetes. Dublin, Ireland, 10 September 1991. J Hypertens Suppl; 1992 Apr; 10(1):S1-53. PubMed ID: 1619498 [No Abstract] [Full Text] [Related]
23. [The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases]. Ferrari R; Ambrosio G; Chiariello M Ital Heart J; 2005 Nov; 6 Suppl 7():3S-4S. PubMed ID: 16485511 [No Abstract] [Full Text] [Related]
25. ACE inhibition--prospects for the future. Satellite symposium to the XIIth Congress of the European Society of Cardiology. Stockholm, September 19, 1990. J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S1-49. PubMed ID: 1725195 [No Abstract] [Full Text] [Related]
26. [Angiotensin receptor blocker often a valuable alternative to ACE inhibitors]. Partanen J Duodecim; 2003; 119(13):1193-6. PubMed ID: 12908180 [No Abstract] [Full Text] [Related]
27. Should we put angiotensin-converting enzyme inhibitors in the water supply? Alpert JS Curr Cardiol Rep; 2002 Jul; 4(4):249-50. PubMed ID: 12052263 [No Abstract] [Full Text] [Related]
28. Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cardiovascular outcomes in chronic dialysis patients: a population-based cohort study. Bajaj RR; Wald R; Hackam DG; Gomes T; Perl J; Juurlink DN; Manno M; Garg AX; Kitchlu A; Mamdani MM; Yan AT Arch Intern Med; 2012 Apr; 172(7):591-3. PubMed ID: 22493468 [No Abstract] [Full Text] [Related]
29. Angiotensin converting enzyme inhibitor-induced renal dysfunction: recommendations for prevention. Cooke HM; De Besse A Int J Clin Pharmacol Ther; 1994 Feb; 32(2):65-70. PubMed ID: 8004361 [TBL] [Abstract][Full Text] [Related]
30. Introduction. The cardiovascular continuum in the 21st century: renin-angiotensin system blockade, the cardiovascular continuum in the 21st century. Probstfield JL; Weber MA Am J Cardiol; 2010 Jan; 105(1 Suppl):1A-2A. PubMed ID: 20102967 [No Abstract] [Full Text] [Related]
34. ACE inhibitors in high risk cardiovascular patients: a new hope from the HOPE study. Gambhir DS Indian Heart J; 2000; 52(2):127-8, 211. PubMed ID: 10893889 [No Abstract] [Full Text] [Related]
35. Angiotensin-converting enzyme inhibitors for bevacizumab-induced hypertension. Dincer M; Altundag K Ann Pharmacother; 2006 Dec; 40(12):2278-9. PubMed ID: 17105834 [No Abstract] [Full Text] [Related]
37. Blockade of the renin-angiotensin system. Cheung BM Hong Kong Med J; 2002 Jun; 8(3):185-91. PubMed ID: 12055364 [TBL] [Abstract][Full Text] [Related]
38. ACE inhibitors for all--'Hope' for the heart and failure for the kidneys? Goldsmith D J Hum Hypertens; 2001 Mar; 15(3):147-51. PubMed ID: 11317197 [No Abstract] [Full Text] [Related]
39. [Efficacy of a new ACE inhibitor zofenopril (zocardis) in cardiovascular diseases]. Ivleva AIa Ter Arkh; 2006; 78(8):89-93. PubMed ID: 17078226 [No Abstract] [Full Text] [Related]
40. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril. Ferrari R Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):15-29. PubMed ID: 15723572 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]